The orally active melanocortin-4 receptor antagonist BL-6020/979: a promising candidate for the treatment of cancer cachexia

The orally active melanocortin-4 receptor antagonist BL-6020/979: a promising candidate for the treatment of cancer cachexia

Item
http://www.wikidata.org/entity/Q35223982
Pathophysiology of anorexia in the cancer cachexia syndromeNonmuscle Tissues Contribution to Cancer CachexiaSystems ChronotherapeuticsSurvival prediction using temporal muscle thickness measurements on cranial magnetic resonance images in patients with newly diagnosed brain metastases.Highlights of mechanistic and therapeutic cachexia and sarcopenia research 2010 to 2012 and their relevance for cardiology.Drugs in development for treatment of patients with cancer-related anorexia and cachexia syndrome.A Novel Prognostic Scoring System Based on Preoperative Sarcopenia Predicts the Long-Term Outcome for Patients After R0 Resection for Gastric Cancer: Experiences of a High-Volume Center.Bench-top to clinical therapies: A review of melanocortin ligands from 1954 to 2016.Skeletal Muscle Measures as Predictors of Toxicity, Hospitalization, and Survival in Patients with Metastatic Breast Cancer Receiving Taxane-Based Chemotherapy.Emerging new therapeutic alternatives for the management of cancer cachexia: recent insights.Editorial update on emerging drugs for cancer cachexia.A Novel Preoperative Skeletal Muscle Measure as a Predictor of Postoperative Complications, Long-Term Survival and Tumor Recurrence for Patients with Gastric Cancer After Radical Gastrectomy.
P2860

The orally active melanocortin-4 receptor antagonist BL-6020/979: a promising candidate for the treatment of cancer cachexia

Item
http://www.wikidata.org/entity/Q35223982
description
2011 nî lūn-bûn
@nan
2011 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
The orally active melanocortin ...... e treatment of cancer cachexia
@ast
The orally active melanocortin ...... e treatment of cancer cachexia
@en
type
label
The orally active melanocortin ...... e treatment of cancer cachexia
@ast
The orally active melanocortin ...... e treatment of cancer cachexia
@en
prefLabel
The orally active melanocortin ...... e treatment of cancer cachexia
@ast
The orally active melanocortin ...... e treatment of cancer cachexia
@en
P1433
P1476
P2093
P2860
P2888
P304
P31
P356
P433
P478
P577
P5875
P698
P932
P356
P1433
P1476
The orally active melanocortin ...... e treatment of cancer cachexia
@en
P2093
P2860
P2888
P304
P31
P356
P433
P478
P577
P5875
P698
P932